SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011022
Filing Date
2024-03-22
Accepted
2024-03-22 17:27:59
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2744984
2 ex3-1.htm EX-3.1 40960
3 ex4-4.htm EX-4.4 32799
4 ex4-5.htm EX-4.5 32676
5 ex10-49.htm EX-10.49 174597
6 ex21-1.htm EX-21.1 7548
7 ex23-1.htm EX-23.1 4828
8 ex31.htm EX-31 33787
9 ex32.htm EX-32 8562
10 ex97-1.htm EX-97.1 39304
11 form10-k_001.jpg GRAPHIC 172720
12 form10-k_002.jpg GRAPHIC 117377
13 form10-k_003.jpg GRAPHIC 25653
  Complete submission text file 0001493152-24-011022.txt   10564913

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE age-20231231.xsd EX-101.SCH 48773
15 XBRL CALCULATION FILE age-20231231_cal.xml EX-101.CAL 63851
16 XBRL DEFINITION FILE age-20231231_def.xml EX-101.DEF 273906
17 XBRL LABEL FILE age-20231231_lab.xml EX-101.LAB 469979
18 XBRL PRESENTATION FILE age-20231231_pre.xml EX-101.PRE 394534
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1317345
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38519 | Film No.: 24776338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)